We are live on ! Find out more
ACIU icon

AC Immune

48 hedge funds and large institutions have $163M invested in AC Immune in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

75% more capital invested

Capital invested by funds: $93M → $163M (+$69.7M)

33% more funds holding

Funds holding: 3648 (+12)

0.45% more ownership

Funds ownership: 27.81%28.26% (+0.45%)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

Holders
48
Holders Change
+12
Holders Change %
+33.33%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
11
Reduced
15
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$96.6M +$297K +44,594 +0.4%
Temasek Holdings
2
Temasek Holdings
Singapore
$22.3M
PM
3
Prosight Management
Texas
$10.6M -$37.4K -5,610 -0.4%
AG
4
Artal Group
Luxembourg
$8.52M
BlackRock
5
BlackRock
New York
$5.31M -$261K -39,093 -6%
Renaissance Technologies
6
Renaissance Technologies
New York
$4.15M +$715K +107,300 +28%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$2.74M +$1.16M +173,555 +118%
Wells Fargo
8
Wells Fargo
California
$1.76M +$666 +100 +0%
TCM
9
Tekla Capital Management
Massachusetts
$1.46M
Marshall Wace
10
Marshall Wace
United Kingdom
$1.16M +$648K +97,217 +249%
AC
11
Athanor Capital
New York
$787K -$108K -16,168 -15%
Citadel Advisors
12
Citadel Advisors
Florida
$700K -$254K -38,169 -32%
Verition Fund Management
13
Verition Fund Management
Connecticut
$695K +$544K +81,602 New
Morgan Stanley
14
Morgan Stanley
New York
$631K -$42.5K -6,384 -8%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$575K -$317K -47,617 -41%
Millennium Management
16
Millennium Management
New York
$426K -$485K -72,828 -59%
AWCI
17
Alpine Woods Capital Investors
New York
$358K +$280K +42,000 New
Goldman Sachs
18
Goldman Sachs
New York
$350K +$89.8K +13,474 +49%
Balyasny Asset Management
19
Balyasny Asset Management
Illinois
$287K +$224K +33,653 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$275K -$137K -20,617 -39%
GCP
21
GSA Capital Partners
United Kingdom
$273K +$23.3K +3,500 +12%
State Street
22
State Street
Massachusetts
$272K -$3.2K -480 -1%
OAM
23
Oxford Asset Management
United Kingdom
$251K +$196K +29,431 New
TI
24
Trexquant Investment
Connecticut
$248K +$194K +29,092 New
SIM
25
Spark Investment Management
New York
$205K +$160K +24,083 New

ACIU Hedge Fund Activity: Q4 2019 in Review

48 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2019, worth a combined $163M — up 75% from $93M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACIU positions and 5 closed out — a net gain of 12 holders — while 11 added to existing stakes and 15 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $1.16M. The largest seller was ALPS Advisors, exiting entirely with an estimated $667K sold.

  • 48 institutional investors held AC Immune (ACIU) as of Q4 2019, up from 36 in Q3 2019.
  • Funds reported $163M of AC Immune stock for Q4 2019, up 75% quarter-over-quarter.
  • 17 funds opened new AC Immune positions in Q4 2019 and 5 closed out, a net change of +12 holders.
  • The largest AC Immune buyer in Q4 2019 was Acadian Asset Management, an estimated $1.16M added.
  • The largest AC Immune seller in Q4 2019 was ALPS Advisors, an estimated $667K sold.

Based on aggregated 13F filings for Q4 2019.